International Journal of Hematology and Oncology 2023, Vol 33, Num 4 Page(s): 211-218

Abdullah ALTINTAŞ1, Timuçin ÇİL2, Orhan AYYILDIZ1

1Dicle Üniversitesi Tıp Fakültesi, İç Hastalıkları, Hematoloji Bilim Dalı, DİYARBAKIR
2Dicle Üniversitesi Tıp Fakültesi, İç Hastalıkları Onkoloji Bilim Dalı, DİYARBAKIR

Keywords: Splenectomy, Splenectomy in lymphoproliferative disorders, Lymphoma
Splenomegaly is common in the course of lymphoproliferative disorders. Massive splenomegaly sometimes leads to bulk symptoms and cytopenias. Splenomegaly may also be the primary manifestation of lymphoproliferative disorders. Splenectomy, with an acceptable surgical risk, has the potential to establish the diagnosis of lymphoproliferative disorders in patient with splenomegaly without lymphadenopathy and negative bone marrow findings. Splenectomy in these group patients is performed for either diagnostic or therapeutic reasons. Splenectomy has the potential to relieve bulk symptoms, correct cytopenias, and facilitate aggressive chemotherapy.